Ipsen Announces Oral And Poster Presentations Of Abobotulinumtoxina Data At The 2017 Annual Meeting Of Post author:Sam Post published:September 14, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Medtronic Receives CE Mark For Its Next Generation Cardiac Resynchronization Therapy-Pacemakers February 23, 2017 Show Me The Money: Bay Area???s Top 5 Venture Capital-Backed Biotechs September 14, 2017 Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017
Medtronic Receives CE Mark For Its Next Generation Cardiac Resynchronization Therapy-Pacemakers February 23, 2017
Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017